Publication:
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.

dc.contributor.authorRodríguez-Fernández, Blanca
dc.contributor.authorVilor-Tejedor, Natalia
dc.contributor.authorArenaza-Urquijo, Eider M
dc.contributor.authorSánchez-Benavides, Gonzalo
dc.contributor.authorSuárez-Calvet, Marc
dc.contributor.authorOperto, Grégory
dc.contributor.authorMinguillón, Carolina
dc.contributor.authorFauria, Karine
dc.contributor.authorKollmorgen, Gwendlyn
dc.contributor.authorSuridjan, Ivonne
dc.contributor.authorde Moura, Manuel Castro
dc.contributor.authorPiñeyro, David
dc.contributor.authorEsteller, Manel
dc.contributor.authorBlennow, Kaj
dc.contributor.authorZetterberg, Henrik
dc.contributor.authorDe Vivo, Immaculata
dc.contributor.authorMolinuevo, José Luis
dc.contributor.authorNavarro, Arcadi
dc.contributor.authorGispert, Juan Domingo
dc.contributor.authorSala-Vila, Aleix
dc.contributor.authorCrous-Bou, Marta
dc.contributor.funderAlzheimers Associationes_ES
dc.contributor.funderFundación La Caixaes_ES
dc.contributor.funderGovernment of Catalonia (España)es_ES
dc.contributor.funderMinisterio de Ciencia, Innovación y Universidades (España)es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España)es_ES
dc.contributor.funderAgencia Estatal de Investigación (España)es_ES
dc.contributor.funderUnión Europea. Comisión Europea. H2020es_ES
dc.contributor.funderInstituto de Salud Carlos IIIes_ES
dc.contributor.funderMarie Curiees_ES
dc.contributor.funderSwedish Research Counciles_ES
dc.date.accessioned2023-04-18T13:15:06Z
dc.date.available2023-04-18T13:15:06Z
dc.date.issued2022-11-07
dc.description.abstractTelomere length (TL) is associated with biological aging, consequently influencing the risk of age-related diseases such as Alzheimer's disease (AD). We aimed to evaluate the potential causal role of TL in AD endophenotypes (i.e., cognitive performance, N = 2233; brain age and AD-related signatures, N = 1134; and cerebrospinal fluid biomarkers (CSF) of AD and neurodegeneration, N = 304) through a Mendelian randomization (MR) analysis. Our analysis was conducted in the context of the ALFA (ALzheimer and FAmilies) study, a population of cognitively healthy individuals at risk of AD. A total of 20 single nucleotide polymorphisms associated with TL were used to determine the effect of TL on AD endophenotypes. Analyses were adjusted by age, sex, and years of education. Stratified analyses by APOE-ɛ4 status and polygenic risk score of AD were conducted. MR analysis revealed significant associations between genetically predicted longer TL and lower levels of CSF Aβ and higher levels of CSF NfL only in APOE-ɛ4 non-carriers. Moreover, inheriting longer TL was associated with greater cortical thickness in age and AD-related brain signatures and lower levels of CSF p-tau among individuals at a high genetic predisposition to AD. Further observational analyses are warranted to better understand these associations.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThe project leading to these results has received funding from the Alzhei‑ mer’s Association (Grant AARG-19-618265). This project has received funding from Instituto de Salud Carlos III (PI19/00119). Additional support has been received from “la Caixa” Foundation (ID 100010434), under agreement LCF/ PR/GN17/50300004, the Alzheimer’s Association and an international anonymous charity foundation through the TriBEKa Imaging Platform project (TriBEKa-17-519007), the Health Department of the Catalan Government (Health Research and Innovation Strategic Plan (PERIS) 2016-2020 grant# SLT002/16/00201), and the Universities and Research Secretariat, Ministry of Business and Knowledge of the Catalan Government under the grant no. 2017-SGR-892. All CRG authors acknowledge the support of the Spanish Ministry of Science, Innovation and Universities to the EMBL partnership, the Centro de Excelencia Severo Ochoa, and the CERCA Programme/Generalitat de Catalunya. NV-T is funded by a post-doctoral grant, Juan de la Cierva Incor‑ poración Programme (IJC2020-043216-I), Ministry of Science and Innovation– Spanish State Research Agency. EMAU is supported by the Spanish Ministry of Science, Innovation and Universities - Spanish State Research Agency (RYC2018-026053-I). MS-C receives funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innova‑ tion programme (Grant agreement no. 948677). MS-C also receives funding from the Instituto de Salud Carlos III (PI19/00155) and from the Spanish Ministry of Science, Innovation and Universities (Juan de la Cierva Programme grant IJC2018-037478-I). HZ is a Wallenberg Scholar supported by grants from the Swedish Research Council (#2018-02532); the European Research Council (#681712); Swedish State Support for Clinical Research (#ALFGBG-720931); the Alzheimer Drug Discovery Foundation (ADDF), USA (#201809-2016862); the AD Strategic Fund and the Alzheimer’s Association (#ADSF-21-831376-C, #ADSF-21-831381-C, and #ADSF-21-831377-C); the Olav Thon Founda‑ tion; the Erling-Persson Family Foundation, Stiftelsen för Gamla Tjänarinnor, Hjärnfonden, Sweden (#FO2019-0228); the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 860197 (MIRIADE); and the UK Dementia Research Institute at UCL. KB is supported by the Swedish Research Council (#2017-00915); the Alzheimer Drug Discovery Foundation (ADDF), USA (#RDAPB-2018092016615); the Swedish Alzheimer Foundation (#AF-742881); Hjärnfonden, Sweden (#FO2017-0243); the Swedish state under the agreement between the Swedish government and the County Councils, the ALF-agreement (#ALFGBG-715986); the European Union Joint Program for Neurodegenera‑ tive Disorders (JPND2019-466-236); and the National Institute of Health (NIH), USA, (grant #1R01AG068398-01). JDG is supported by the Spanish Ministry of Science and Innovation (RYC-2013-13054). AS-V. is the recipient of an Instituto de Salud Carlos III Miguel Servet II fellowship (CP II 17/00029).es_ES
dc.format.number1es_ES
dc.format.page167es_ES
dc.format.volume14es_ES
dc.identifier.citationAlzheimers Res Ther. 2022 Nov 7;14(1):167es_ES
dc.identifier.doi10.1186/s13195-022-01101-9es_ES
dc.identifier.e-issn1758-9193es_ES
dc.identifier.journalAlzheimer's research & therapyes_ES
dc.identifier.pubmedID36345036es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15838
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC)es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/AARG-19-618265es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI19/00119es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/ID/100010434es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PR/GN17/50300004es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IJC2020-043216-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RYC2018-026053-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI19/00155es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/IJC2018-037478-Ies_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RYC-2013-13054es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/948677es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s13195-022-01101-9es_ES
dc.repisalud.institucionCNICes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subject.meshAlzheimer Diseasees_ES
dc.subject.meshHumanses_ES
dc.subject.meshMendelian Randomization Analysises_ES
dc.subject.meshEndophenotypeses_ES
dc.subject.meshBiomarkerses_ES
dc.subject.meshApolipoproteins Ees_ES
dc.subject.meshTelomerees_ES
dc.subject.meshtau Proteinses_ES
dc.subject.meshAmyloid beta-Peptideses_ES
dc.titleGenetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication938ecefe-e43b-4f94-a273-4338f77af450
relation.isAuthorOfPublication.latestForDiscovery938ecefe-e43b-4f94-a273-4338f77af450

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Genetically predicted telomere Alzheimers Res Ther 2022.pdf
Size:
3.26 MB
Format:
Adobe Portable Document Format
Description:
Artículo